α mem Search Results


99
Cytiva Europe ribo y deoxyribonucleosides
Ribo Y Deoxyribonucleosides, supplied by Cytiva Europe, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/%CE%B1+mem/HyClone+MEM+Alpha+modification+liquid+with+L-glutamine/bio_rxiv__64898__2026__01__19__700325-146-15-18
Average 99 stars, based on 1 article reviews
ribo y deoxyribonucleosides - by Bioz Stars, 2026-11
99/100 stars
  Buy from Supplier

95
Beijing Solarbio Science α mem
α Mem, supplied by Beijing Solarbio Science, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/%CE%B1+mem/alpha-MEM/pmc06913167-59-7-14
Average 95 stars, based on 1 article reviews
α mem - by Bioz Stars, 2026-11
95/100 stars
  Buy from Supplier

96
GE Healthcare eagle s medium
Eagle S Medium, supplied by GE Healthcare, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/%CE%B1+mem/MEM+Alpha+modification%2C+with+L-glutamine%2C+ribo-+and+deoxyribonucleosides/pmc08524704-41-39-44
Average 96 stars, based on 1 article reviews
eagle s medium - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

93
Miltenyi Biotec apc cy7 cd48 hm48 1 cell surface markers
Apc Cy7 Cd48 Hm48 1 Cell Surface Markers, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/%CE%B1+mem/CD48+Antibody%2C+anti-mouse/10__1172_slash_jci191713-301-20-12
Average 93 stars, based on 1 article reviews
apc cy7 cd48 hm48 1 cell surface markers - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

98
AvesLabs chicken anti nfm
Non-NMDAR autoantibodies from three patients with anti-NMDAR encephalitis colocalized with axons. Primary culture of rat cortical neurons after day 18 in vitro. Rat brain sections were analyzed using immunofluorescent staining. Serum from patients showed strong binding to the primary culture neurons, whereas that from healthy controls did not (A). Double labeling with <t>anti-NFM</t> antibody revealed the typical distribution of axons, overlapping with patients' serum (B, bottom). There was no colocalization with the dendritic marker MAP2 (B, middle) or the astrocyte marker GFAP that labels the astrocytic end feet in contact with the blood vessels (B, top). High magnification (×200) confocal images showed non-NMDAR antibody/NFM colocalization. Anti-MAP2 staining was clearly visible in the dendrites of pyramidal cells, whereas patients with non-NMDAR autoantibodies displayed the neurophil and axon staining that typically appears in the rat hippocampus and cerebellum (C, boxed areas are enlarged in the last column). Scale bar=20 µm (A and B). Scale bar=100 µm (C). GFAP: glial fibrillary acidic protein, NFM: medium neurofilament, NMDAR: N-methyl-D-aspartate receptor.
Chicken Anti Nfm, supplied by AvesLabs, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/%CE%B1+mem/Anti-NFM+(Neurofilament+Medium+Chain)+Antibody/pmc07354960-70-13-16
Average 98 stars, based on 1 article reviews
chicken anti nfm - by Bioz Stars, 2026-11
98/100 stars
  Buy from Supplier

90
Miltenyi Biotec cd48 apc
A Procedure followed to identify populations of murine cells that take in fluorescent ALL EVs. B Flow cytometry on total BM cells demonstrating that primitive hematopoietic cells (Sca1 + mCD45 + ) take in fluorescent T-ALL and B-ALL EVs (ATTO488 EVs). C Flow cytometry gating strategy used to analyze further subpopulations among the primitive Lin − cells and their capacity to take in ALL EVs. D Mean fluorescence intensity (MFI) on Lin − cells showing that HSPC (LSK; Lin − Sca1 + c-Kit + ) and HSC (SLAM; LSK CD150 + <t>CD48</t> − ) can take in ALL EVs (ATTO488 EVs), while LK (Lin − c-Kit + Sca1 − ) cells and the c-Kit negative (c-Kit − ) cells cannot. The intake of SLAM cells was higher than LSK cells. Data are compared to c-Kit − cells and are shown as means ± SD; n = 3 mice. P value measured by one-way Anova with Tukey’s multiple comparison test; $ P < 0.0001. E Among Lin − cells, cells showing intake of ALL EVs (ATTO488 EVs positive cells; pos) and no intake (ATTO488 EVs negative cells; neg). To examine the cell intake of EVs, Lin − cells are treated with HSP70-ATTO488 EVs, for 30 min to 2 h. Data showing that ALL EVs have the potential to rapidly bind, within 30 min, ~4% of the Lin − cells. Data are shown as means ± SD; n = 4 biological replicates. P value measured by one-way Anova with Tukey’s multiple comparison test; **** P < 0.0001. F CFU assay is assessed for 30,000 pos and neg cells purified by FACS, after 7 days on semi-solid media. Data showing that pos cells are more primitive, while they produce more CFU-GM colonies when compared with neg cells. Quantity of CFU (left panel) and distribution (right panel). Data are shown as means ± SD; n = 3 mice. P value measured by two-tailed unpaired Student’s t test; **** P < 0.0001; ns, non-significant.
Cd48 Apc, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/%CE%B1+mem/CD48+Antibody%2C+anti-mouse%2C+REAfinity/pmc09005650-325-30-33
Average 90 stars, based on 1 article reviews
cd48 apc - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

96
Danaher Inc mem alpha modification
A Procedure followed to identify populations of murine cells that take in fluorescent ALL EVs. B Flow cytometry on total BM cells demonstrating that primitive hematopoietic cells (Sca1 + mCD45 + ) take in fluorescent T-ALL and B-ALL EVs (ATTO488 EVs). C Flow cytometry gating strategy used to analyze further subpopulations among the primitive Lin − cells and their capacity to take in ALL EVs. D Mean fluorescence intensity (MFI) on Lin − cells showing that HSPC (LSK; Lin − Sca1 + c-Kit + ) and HSC (SLAM; LSK CD150 + <t>CD48</t> − ) can take in ALL EVs (ATTO488 EVs), while LK (Lin − c-Kit + Sca1 − ) cells and the c-Kit negative (c-Kit − ) cells cannot. The intake of SLAM cells was higher than LSK cells. Data are compared to c-Kit − cells and are shown as means ± SD; n = 3 mice. P value measured by one-way Anova with Tukey’s multiple comparison test; $ P < 0.0001. E Among Lin − cells, cells showing intake of ALL EVs (ATTO488 EVs positive cells; pos) and no intake (ATTO488 EVs negative cells; neg). To examine the cell intake of EVs, Lin − cells are treated with HSP70-ATTO488 EVs, for 30 min to 2 h. Data showing that ALL EVs have the potential to rapidly bind, within 30 min, ~4% of the Lin − cells. Data are shown as means ± SD; n = 4 biological replicates. P value measured by one-way Anova with Tukey’s multiple comparison test; **** P < 0.0001. F CFU assay is assessed for 30,000 pos and neg cells purified by FACS, after 7 days on semi-solid media. Data showing that pos cells are more primitive, while they produce more CFU-GM colonies when compared with neg cells. Quantity of CFU (left panel) and distribution (right panel). Data are shown as means ± SD; n = 3 mice. P value measured by two-tailed unpaired Student’s t test; **** P < 0.0001; ns, non-significant.
Mem Alpha Modification, supplied by Danaher Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/%CE%B1+mem/MEM%2F+Alpha+modification+without+L-glutamine%2C+ribo-+and+deoxyribonucleosides/pmc08329988-36-8-17
Average 96 stars, based on 1 article reviews
mem alpha modification - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

96
Miltenyi Biotec texmacstm gmp medium
A Procedure followed to identify populations of murine cells that take in fluorescent ALL EVs. B Flow cytometry on total BM cells demonstrating that primitive hematopoietic cells (Sca1 + mCD45 + ) take in fluorescent T-ALL and B-ALL EVs (ATTO488 EVs). C Flow cytometry gating strategy used to analyze further subpopulations among the primitive Lin − cells and their capacity to take in ALL EVs. D Mean fluorescence intensity (MFI) on Lin − cells showing that HSPC (LSK; Lin − Sca1 + c-Kit + ) and HSC (SLAM; LSK CD150 + <t>CD48</t> − ) can take in ALL EVs (ATTO488 EVs), while LK (Lin − c-Kit + Sca1 − ) cells and the c-Kit negative (c-Kit − ) cells cannot. The intake of SLAM cells was higher than LSK cells. Data are compared to c-Kit − cells and are shown as means ± SD; n = 3 mice. P value measured by one-way Anova with Tukey’s multiple comparison test; $ P < 0.0001. E Among Lin − cells, cells showing intake of ALL EVs (ATTO488 EVs positive cells; pos) and no intake (ATTO488 EVs negative cells; neg). To examine the cell intake of EVs, Lin − cells are treated with HSP70-ATTO488 EVs, for 30 min to 2 h. Data showing that ALL EVs have the potential to rapidly bind, within 30 min, ~4% of the Lin − cells. Data are shown as means ± SD; n = 4 biological replicates. P value measured by one-way Anova with Tukey’s multiple comparison test; **** P < 0.0001. F CFU assay is assessed for 30,000 pos and neg cells purified by FACS, after 7 days on semi-solid media. Data showing that pos cells are more primitive, while they produce more CFU-GM colonies when compared with neg cells. Quantity of CFU (left panel) and distribution (right panel). Data are shown as means ± SD; n = 3 mice. P value measured by two-tailed unpaired Student’s t test; **** P < 0.0001; ns, non-significant.
Texmacstm Gmp Medium, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/%CE%B1+mem/TexMACS+GMP+Medium/us12577533-168-27-30
Average 96 stars, based on 1 article reviews
texmacstm gmp medium - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

85
Diaclone cd80 fitc
A Procedure followed to identify populations of murine cells that take in fluorescent ALL EVs. B Flow cytometry on total BM cells demonstrating that primitive hematopoietic cells (Sca1 + mCD45 + ) take in fluorescent T-ALL and B-ALL EVs (ATTO488 EVs). C Flow cytometry gating strategy used to analyze further subpopulations among the primitive Lin − cells and their capacity to take in ALL EVs. D Mean fluorescence intensity (MFI) on Lin − cells showing that HSPC (LSK; Lin − Sca1 + c-Kit + ) and HSC (SLAM; LSK CD150 + <t>CD48</t> − ) can take in ALL EVs (ATTO488 EVs), while LK (Lin − c-Kit + Sca1 − ) cells and the c-Kit negative (c-Kit − ) cells cannot. The intake of SLAM cells was higher than LSK cells. Data are compared to c-Kit − cells and are shown as means ± SD; n = 3 mice. P value measured by one-way Anova with Tukey’s multiple comparison test; $ P < 0.0001. E Among Lin − cells, cells showing intake of ALL EVs (ATTO488 EVs positive cells; pos) and no intake (ATTO488 EVs negative cells; neg). To examine the cell intake of EVs, Lin − cells are treated with HSP70-ATTO488 EVs, for 30 min to 2 h. Data showing that ALL EVs have the potential to rapidly bind, within 30 min, ~4% of the Lin − cells. Data are shown as means ± SD; n = 4 biological replicates. P value measured by one-way Anova with Tukey’s multiple comparison test; **** P < 0.0001. F CFU assay is assessed for 30,000 pos and neg cells purified by FACS, after 7 days on semi-solid media. Data showing that pos cells are more primitive, while they produce more CFU-GM colonies when compared with neg cells. Quantity of CFU (left panel) and distribution (right panel). Data are shown as means ± SD; n = 3 mice. P value measured by two-tailed unpaired Student’s t test; **** P < 0.0001; ns, non-significant.
Cd80 Fitc, supplied by Diaclone, used in various techniques. Bioz Stars score: 85/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/%CE%B1+mem/Anti-Human+CD80+Monoclonal+Antibody%2C+FITC+Conjugated+Clone+MEM-233/pmc01809463-149-25-28
Average 85 stars, based on 1 article reviews
cd80 fitc - by Bioz Stars, 2026-11
85/100 stars
  Buy from Supplier

93
Diaclone cd105
A Procedure followed to identify populations of murine cells that take in fluorescent ALL EVs. B Flow cytometry on total BM cells demonstrating that primitive hematopoietic cells (Sca1 + mCD45 + ) take in fluorescent T-ALL and B-ALL EVs (ATTO488 EVs). C Flow cytometry gating strategy used to analyze further subpopulations among the primitive Lin − cells and their capacity to take in ALL EVs. D Mean fluorescence intensity (MFI) on Lin − cells showing that HSPC (LSK; Lin − Sca1 + c-Kit + ) and HSC (SLAM; LSK CD150 + <t>CD48</t> − ) can take in ALL EVs (ATTO488 EVs), while LK (Lin − c-Kit + Sca1 − ) cells and the c-Kit negative (c-Kit − ) cells cannot. The intake of SLAM cells was higher than LSK cells. Data are compared to c-Kit − cells and are shown as means ± SD; n = 3 mice. P value measured by one-way Anova with Tukey’s multiple comparison test; $ P < 0.0001. E Among Lin − cells, cells showing intake of ALL EVs (ATTO488 EVs positive cells; pos) and no intake (ATTO488 EVs negative cells; neg). To examine the cell intake of EVs, Lin − cells are treated with HSP70-ATTO488 EVs, for 30 min to 2 h. Data showing that ALL EVs have the potential to rapidly bind, within 30 min, ~4% of the Lin − cells. Data are shown as means ± SD; n = 4 biological replicates. P value measured by one-way Anova with Tukey’s multiple comparison test; **** P < 0.0001. F CFU assay is assessed for 30,000 pos and neg cells purified by FACS, after 7 days on semi-solid media. Data showing that pos cells are more primitive, while they produce more CFU-GM colonies when compared with neg cells. Quantity of CFU (left panel) and distribution (right panel). Data are shown as means ± SD; n = 3 mice. P value measured by two-tailed unpaired Student’s t test; **** P < 0.0001; ns, non-significant.
Cd105, supplied by Diaclone, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/%CE%B1+mem/Anti-Human+CD105+Monoclonal+Antibody%2C+Unconjugated+Clone+MEM-226/pmc03492496-73-36-37
Average 93 stars, based on 1 article reviews
cd105 - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

90
Boster Bio neurofilament medium chain
A Procedure followed to identify populations of murine cells that take in fluorescent ALL EVs. B Flow cytometry on total BM cells demonstrating that primitive hematopoietic cells (Sca1 + mCD45 + ) take in fluorescent T-ALL and B-ALL EVs (ATTO488 EVs). C Flow cytometry gating strategy used to analyze further subpopulations among the primitive Lin − cells and their capacity to take in ALL EVs. D Mean fluorescence intensity (MFI) on Lin − cells showing that HSPC (LSK; Lin − Sca1 + c-Kit + ) and HSC (SLAM; LSK CD150 + <t>CD48</t> − ) can take in ALL EVs (ATTO488 EVs), while LK (Lin − c-Kit + Sca1 − ) cells and the c-Kit negative (c-Kit − ) cells cannot. The intake of SLAM cells was higher than LSK cells. Data are compared to c-Kit − cells and are shown as means ± SD; n = 3 mice. P value measured by one-way Anova with Tukey’s multiple comparison test; $ P < 0.0001. E Among Lin − cells, cells showing intake of ALL EVs (ATTO488 EVs positive cells; pos) and no intake (ATTO488 EVs negative cells; neg). To examine the cell intake of EVs, Lin − cells are treated with HSP70-ATTO488 EVs, for 30 min to 2 h. Data showing that ALL EVs have the potential to rapidly bind, within 30 min, ~4% of the Lin − cells. Data are shown as means ± SD; n = 4 biological replicates. P value measured by one-way Anova with Tukey’s multiple comparison test; **** P < 0.0001. F CFU assay is assessed for 30,000 pos and neg cells purified by FACS, after 7 days on semi-solid media. Data showing that pos cells are more primitive, while they produce more CFU-GM colonies when compared with neg cells. Quantity of CFU (left panel) and distribution (right panel). Data are shown as means ± SD; n = 3 mice. P value measured by two-tailed unpaired Student’s t test; **** P < 0.0001; ns, non-significant.
Neurofilament Medium Chain, supplied by Boster Bio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/%CE%B1+mem/Anti-Neurofilament+Medium+NF-M+Monoclonal+Antibody/10__3390_slash_ijms27083342-232-47-52
Average 90 stars, based on 1 article reviews
neurofilament medium chain - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

93
Diaclone cd105 fitc
A Procedure followed to identify populations of murine cells that take in fluorescent ALL EVs. B Flow cytometry on total BM cells demonstrating that primitive hematopoietic cells (Sca1 + mCD45 + ) take in fluorescent T-ALL and B-ALL EVs (ATTO488 EVs). C Flow cytometry gating strategy used to analyze further subpopulations among the primitive Lin − cells and their capacity to take in ALL EVs. D Mean fluorescence intensity (MFI) on Lin − cells showing that HSPC (LSK; Lin − Sca1 + c-Kit + ) and HSC (SLAM; LSK CD150 + <t>CD48</t> − ) can take in ALL EVs (ATTO488 EVs), while LK (Lin − c-Kit + Sca1 − ) cells and the c-Kit negative (c-Kit − ) cells cannot. The intake of SLAM cells was higher than LSK cells. Data are compared to c-Kit − cells and are shown as means ± SD; n = 3 mice. P value measured by one-way Anova with Tukey’s multiple comparison test; $ P < 0.0001. E Among Lin − cells, cells showing intake of ALL EVs (ATTO488 EVs positive cells; pos) and no intake (ATTO488 EVs negative cells; neg). To examine the cell intake of EVs, Lin − cells are treated with HSP70-ATTO488 EVs, for 30 min to 2 h. Data showing that ALL EVs have the potential to rapidly bind, within 30 min, ~4% of the Lin − cells. Data are shown as means ± SD; n = 4 biological replicates. P value measured by one-way Anova with Tukey’s multiple comparison test; **** P < 0.0001. F CFU assay is assessed for 30,000 pos and neg cells purified by FACS, after 7 days on semi-solid media. Data showing that pos cells are more primitive, while they produce more CFU-GM colonies when compared with neg cells. Quantity of CFU (left panel) and distribution (right panel). Data are shown as means ± SD; n = 3 mice. P value measured by two-tailed unpaired Student’s t test; **** P < 0.0001; ns, non-significant.
Cd105 Fitc, supplied by Diaclone, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/%CE%B1+mem/Anti-Human+CD105+Monoclonal+Antibody%2C+FITC+Conjugated+Clone+MEM-226/pmc03485378-136-49-51
Average 93 stars, based on 1 article reviews
cd105 fitc - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

Image Search Results


Non-NMDAR autoantibodies from three patients with anti-NMDAR encephalitis colocalized with axons. Primary culture of rat cortical neurons after day 18 in vitro. Rat brain sections were analyzed using immunofluorescent staining. Serum from patients showed strong binding to the primary culture neurons, whereas that from healthy controls did not (A). Double labeling with anti-NFM antibody revealed the typical distribution of axons, overlapping with patients' serum (B, bottom). There was no colocalization with the dendritic marker MAP2 (B, middle) or the astrocyte marker GFAP that labels the astrocytic end feet in contact with the blood vessels (B, top). High magnification (×200) confocal images showed non-NMDAR antibody/NFM colocalization. Anti-MAP2 staining was clearly visible in the dendrites of pyramidal cells, whereas patients with non-NMDAR autoantibodies displayed the neurophil and axon staining that typically appears in the rat hippocampus and cerebellum (C, boxed areas are enlarged in the last column). Scale bar=20 µm (A and B). Scale bar=100 µm (C). GFAP: glial fibrillary acidic protein, NFM: medium neurofilament, NMDAR: N-methyl-D-aspartate receptor.

Journal: Journal of Clinical Neurology (Seoul, Korea)

Article Title: Identification of Medium-Length Antineurofilament Autoantibodies in Patients with Anti-N-Methyl-D-Aspartate Receptor Encephalitis

doi: 10.3988/jcn.2020.16.3.470

Figure Lengend Snippet: Non-NMDAR autoantibodies from three patients with anti-NMDAR encephalitis colocalized with axons. Primary culture of rat cortical neurons after day 18 in vitro. Rat brain sections were analyzed using immunofluorescent staining. Serum from patients showed strong binding to the primary culture neurons, whereas that from healthy controls did not (A). Double labeling with anti-NFM antibody revealed the typical distribution of axons, overlapping with patients' serum (B, bottom). There was no colocalization with the dendritic marker MAP2 (B, middle) or the astrocyte marker GFAP that labels the astrocytic end feet in contact with the blood vessels (B, top). High magnification (×200) confocal images showed non-NMDAR antibody/NFM colocalization. Anti-MAP2 staining was clearly visible in the dendrites of pyramidal cells, whereas patients with non-NMDAR autoantibodies displayed the neurophil and axon staining that typically appears in the rat hippocampus and cerebellum (C, boxed areas are enlarged in the last column). Scale bar=20 µm (A and B). Scale bar=100 µm (C). GFAP: glial fibrillary acidic protein, NFM: medium neurofilament, NMDAR: N-methyl-D-aspartate receptor.

Article Snippet: The sections were then exposed to human serum (1:100) with commercial antibodies to chicken anti-NFM (1:500; Aves Labs, Tigard, OR, USA) and mouse anti-microtubule-associated protein 2 (MAP2; 1:500; Merck Millipore, Billerica, MA, USA) as neuronal markers at 4℃ overnight.

Techniques: In Vitro, Staining, Binding Assay, Labeling, Marker

Identification of NFM as the target antigen of non-NMDAR autoantibodies. We cotransfected HEK293T cells with GFP and NFM, NFH, NFL, or βIII-tubulin (A, column 1); column 2 shows the immunostaining for a commercially available antibody in red, and column 3 shows the merged reactivities. The non-NMDAR autoantibodies in the serum from patients reacted with HEK293T cells expressing human NFM in a fluorescence-based cell-binding assay (B). From top to bottom: binding of antibodies from patients' serum or CSF using an antihuman immunoglobulin G secondary antibody (red) to cells transfected with human NFM (green), merged images (yellow), and the absence of staining of nontransfected cells. Patients with anti-NMDAR encephalitis were negative for NFH, NFL, and βIII-tubulin antibodies, while cells displayed filamentous patterns. No binding was observed when using healthy serum. Representative results obtained by Western blotting (“P” and “C” indicate specific patients and controls, respectively) (C). Whole-cell lysates prepared from human HEK293T cells with (+) or without (−) transfection of the human NFM gene were subjected to sodium dodecyl sulfate–polyacrylamide gel electrophoresis. The blots were exposed to serum from seven patients with anti-NMDAR encephalitis and seven healthy controls (C1–C3) after a total of 20 µg of protein lysates from HEK293T cells. Antibodies that bound to the HEK293T cell lysates transfected with NFM that predominantly reacted with one antigen of approximately 160 kDa were seen in serum (diluted 1:100) from patients 3, 13, 24, 39, 43, 46, and 51. This binding was not observed in controls. No protein bands against the HEK293T cells without transfection (as negative controls) were detected in any of the samples. NFM was detected using commercially available anti-NFM antibodies as a positive control. Scale bar=20 µm. CSF: cerebrospinal fluid, GFP: green fluorescent protein, HEK: human embryonic kidney, NFH: heavy neurofilament, NFL: light neurofilament, NFM: medium neurofilament, NMDAR: N-methyl-D-aspartate receptor.

Journal: Journal of Clinical Neurology (Seoul, Korea)

Article Title: Identification of Medium-Length Antineurofilament Autoantibodies in Patients with Anti-N-Methyl-D-Aspartate Receptor Encephalitis

doi: 10.3988/jcn.2020.16.3.470

Figure Lengend Snippet: Identification of NFM as the target antigen of non-NMDAR autoantibodies. We cotransfected HEK293T cells with GFP and NFM, NFH, NFL, or βIII-tubulin (A, column 1); column 2 shows the immunostaining for a commercially available antibody in red, and column 3 shows the merged reactivities. The non-NMDAR autoantibodies in the serum from patients reacted with HEK293T cells expressing human NFM in a fluorescence-based cell-binding assay (B). From top to bottom: binding of antibodies from patients' serum or CSF using an antihuman immunoglobulin G secondary antibody (red) to cells transfected with human NFM (green), merged images (yellow), and the absence of staining of nontransfected cells. Patients with anti-NMDAR encephalitis were negative for NFH, NFL, and βIII-tubulin antibodies, while cells displayed filamentous patterns. No binding was observed when using healthy serum. Representative results obtained by Western blotting (“P” and “C” indicate specific patients and controls, respectively) (C). Whole-cell lysates prepared from human HEK293T cells with (+) or without (−) transfection of the human NFM gene were subjected to sodium dodecyl sulfate–polyacrylamide gel electrophoresis. The blots were exposed to serum from seven patients with anti-NMDAR encephalitis and seven healthy controls (C1–C3) after a total of 20 µg of protein lysates from HEK293T cells. Antibodies that bound to the HEK293T cell lysates transfected with NFM that predominantly reacted with one antigen of approximately 160 kDa were seen in serum (diluted 1:100) from patients 3, 13, 24, 39, 43, 46, and 51. This binding was not observed in controls. No protein bands against the HEK293T cells without transfection (as negative controls) were detected in any of the samples. NFM was detected using commercially available anti-NFM antibodies as a positive control. Scale bar=20 µm. CSF: cerebrospinal fluid, GFP: green fluorescent protein, HEK: human embryonic kidney, NFH: heavy neurofilament, NFL: light neurofilament, NFM: medium neurofilament, NMDAR: N-methyl-D-aspartate receptor.

Article Snippet: The sections were then exposed to human serum (1:100) with commercial antibodies to chicken anti-NFM (1:500; Aves Labs, Tigard, OR, USA) and mouse anti-microtubule-associated protein 2 (MAP2; 1:500; Merck Millipore, Billerica, MA, USA) as neuronal markers at 4℃ overnight.

Techniques: Immunostaining, Expressing, Fluorescence, Cell Binding Assay, Binding Assay, Transfection, Staining, Western Blot, Polyacrylamide Gel Electrophoresis, Positive Control

Clinical features of anti-NMDAR encephalitis patients with  anti-NFM   antibodies

Journal: Journal of Clinical Neurology (Seoul, Korea)

Article Title: Identification of Medium-Length Antineurofilament Autoantibodies in Patients with Anti-N-Methyl-D-Aspartate Receptor Encephalitis

doi: 10.3988/jcn.2020.16.3.470

Figure Lengend Snippet: Clinical features of anti-NMDAR encephalitis patients with anti-NFM antibodies

Article Snippet: The sections were then exposed to human serum (1:100) with commercial antibodies to chicken anti-NFM (1:500; Aves Labs, Tigard, OR, USA) and mouse anti-microtubule-associated protein 2 (MAP2; 1:500; Merck Millipore, Billerica, MA, USA) as neuronal markers at 4℃ overnight.

Techniques:

Comparison between anti-NMDAR encephalitis patients with and without  anti-NFM   antibodies

Journal: Journal of Clinical Neurology (Seoul, Korea)

Article Title: Identification of Medium-Length Antineurofilament Autoantibodies in Patients with Anti-N-Methyl-D-Aspartate Receptor Encephalitis

doi: 10.3988/jcn.2020.16.3.470

Figure Lengend Snippet: Comparison between anti-NMDAR encephalitis patients with and without anti-NFM antibodies

Article Snippet: The sections were then exposed to human serum (1:100) with commercial antibodies to chicken anti-NFM (1:500; Aves Labs, Tigard, OR, USA) and mouse anti-microtubule-associated protein 2 (MAP2; 1:500; Merck Millipore, Billerica, MA, USA) as neuronal markers at 4℃ overnight.

Techniques:

A Procedure followed to identify populations of murine cells that take in fluorescent ALL EVs. B Flow cytometry on total BM cells demonstrating that primitive hematopoietic cells (Sca1 + mCD45 + ) take in fluorescent T-ALL and B-ALL EVs (ATTO488 EVs). C Flow cytometry gating strategy used to analyze further subpopulations among the primitive Lin − cells and their capacity to take in ALL EVs. D Mean fluorescence intensity (MFI) on Lin − cells showing that HSPC (LSK; Lin − Sca1 + c-Kit + ) and HSC (SLAM; LSK CD150 + CD48 − ) can take in ALL EVs (ATTO488 EVs), while LK (Lin − c-Kit + Sca1 − ) cells and the c-Kit negative (c-Kit − ) cells cannot. The intake of SLAM cells was higher than LSK cells. Data are compared to c-Kit − cells and are shown as means ± SD; n = 3 mice. P value measured by one-way Anova with Tukey’s multiple comparison test; $ P < 0.0001. E Among Lin − cells, cells showing intake of ALL EVs (ATTO488 EVs positive cells; pos) and no intake (ATTO488 EVs negative cells; neg). To examine the cell intake of EVs, Lin − cells are treated with HSP70-ATTO488 EVs, for 30 min to 2 h. Data showing that ALL EVs have the potential to rapidly bind, within 30 min, ~4% of the Lin − cells. Data are shown as means ± SD; n = 4 biological replicates. P value measured by one-way Anova with Tukey’s multiple comparison test; **** P < 0.0001. F CFU assay is assessed for 30,000 pos and neg cells purified by FACS, after 7 days on semi-solid media. Data showing that pos cells are more primitive, while they produce more CFU-GM colonies when compared with neg cells. Quantity of CFU (left panel) and distribution (right panel). Data are shown as means ± SD; n = 3 mice. P value measured by two-tailed unpaired Student’s t test; **** P < 0.0001; ns, non-significant.

Journal: Cell Death & Disease

Article Title: Acute lymphoblastic leukemia-derived extracellular vesicles affect quiescence of hematopoietic stem and progenitor cells

doi: 10.1038/s41419-022-04761-5

Figure Lengend Snippet: A Procedure followed to identify populations of murine cells that take in fluorescent ALL EVs. B Flow cytometry on total BM cells demonstrating that primitive hematopoietic cells (Sca1 + mCD45 + ) take in fluorescent T-ALL and B-ALL EVs (ATTO488 EVs). C Flow cytometry gating strategy used to analyze further subpopulations among the primitive Lin − cells and their capacity to take in ALL EVs. D Mean fluorescence intensity (MFI) on Lin − cells showing that HSPC (LSK; Lin − Sca1 + c-Kit + ) and HSC (SLAM; LSK CD150 + CD48 − ) can take in ALL EVs (ATTO488 EVs), while LK (Lin − c-Kit + Sca1 − ) cells and the c-Kit negative (c-Kit − ) cells cannot. The intake of SLAM cells was higher than LSK cells. Data are compared to c-Kit − cells and are shown as means ± SD; n = 3 mice. P value measured by one-way Anova with Tukey’s multiple comparison test; $ P < 0.0001. E Among Lin − cells, cells showing intake of ALL EVs (ATTO488 EVs positive cells; pos) and no intake (ATTO488 EVs negative cells; neg). To examine the cell intake of EVs, Lin − cells are treated with HSP70-ATTO488 EVs, for 30 min to 2 h. Data showing that ALL EVs have the potential to rapidly bind, within 30 min, ~4% of the Lin − cells. Data are shown as means ± SD; n = 4 biological replicates. P value measured by one-way Anova with Tukey’s multiple comparison test; **** P < 0.0001. F CFU assay is assessed for 30,000 pos and neg cells purified by FACS, after 7 days on semi-solid media. Data showing that pos cells are more primitive, while they produce more CFU-GM colonies when compared with neg cells. Quantity of CFU (left panel) and distribution (right panel). Data are shown as means ± SD; n = 3 mice. P value measured by two-tailed unpaired Student’s t test; **** P < 0.0001; ns, non-significant.

Article Snippet: We used the following antibodies; Sca1-APC-Cy7 (1:100, 108126, Biolegend, Paris, France), Sca1-VB-FITC (1:100, 130-116-490, Miltenyi Biotec), CD48-PE-Cy7 (1:100, 560731, BD Biosciences, Le Pont de Claix, France), CD48-FITC (1:100, 103404, Biolegend), CD48-APC (1:100, 130-124-727, Miltenyi Biotec), c-Kit-BV650 (1:100, 135125, Biolegend), c-Kit-PE-Cy7 (1:100, 558163, BD Biosciences), CD150-PerCP-Cy5.5 (1:100, 115921, Biolegend), murine CD45.2-Vioblue (1:100, 130-102-980, Miltenyi Biotec).

Techniques: Flow Cytometry, Fluorescence, Comparison, Colony-forming Unit Assay, Purification, Two Tailed Test

A NSG mice were injected with fluorescent EVs (ATTO488 EVs) by i.v. injections at 10 10 particles/mouse. Mice were sacrificed 24 h after the injection, and florescence was determined by flow cytometry on Lin − , LSK (c-Kit + Sca1 + ) and SLAM (LSK CD150 + CD48 − ) cells. B Procedure followed to treat NSG mice with ALL EVs or control EVs, through three consecutive i.v. injections, at 10 10 particles/mouse/every 10 days. Ten days after the third injection, mice were sacrificed to perform experiments on Sca1 + cells. C The absolute number of Sca1 + cells detected in BM. Data are shown as means ± SD; n = 4 mice. D The number of hematopoietic progenitors (CD45 + Sca1 + c-Kit + cells) and HSC (SLAM; LSK CD150 + CD48 − cells) were determined by flow cytometry. Data are shown as means ± SD; n = 4 mice. E Sca1 + cells (10 5 cells) isolated from mice were analyzed on semi-solid methylcellulose media for growth of murine hematopoietic CFU. Data show the percentage of total CFU and CFU-GM per Sca1 + cells, as well as the distribution among colonies. Data are shown as means ± SD; n = 4 mice. F Sca1 + cells (3 × 10 5 cells) were injected in C57BL/6.SJL (Ly.1) mice and the hematopoietic reconstitution was examined by flow cytometry, 4 weeks after the transplantation. Absolute number of CD45.2 total and Lin − BM cells. Data are shown as means ± SD; n = 3 transplanted mice. G Hematopoietic reconstitution for progenitors (LSK cells) and HSC (SLAM cells). Absolute number of CD45.2 cells in BM. Data are shown as means ± SD; n = 3 transplanted mice. On this figure, P value is measured by one-way Anova with Tukey’s multiple comparison test; ** P < 0.01; *** P < 0.001; ns, non-significant.

Journal: Cell Death & Disease

Article Title: Acute lymphoblastic leukemia-derived extracellular vesicles affect quiescence of hematopoietic stem and progenitor cells

doi: 10.1038/s41419-022-04761-5

Figure Lengend Snippet: A NSG mice were injected with fluorescent EVs (ATTO488 EVs) by i.v. injections at 10 10 particles/mouse. Mice were sacrificed 24 h after the injection, and florescence was determined by flow cytometry on Lin − , LSK (c-Kit + Sca1 + ) and SLAM (LSK CD150 + CD48 − ) cells. B Procedure followed to treat NSG mice with ALL EVs or control EVs, through three consecutive i.v. injections, at 10 10 particles/mouse/every 10 days. Ten days after the third injection, mice were sacrificed to perform experiments on Sca1 + cells. C The absolute number of Sca1 + cells detected in BM. Data are shown as means ± SD; n = 4 mice. D The number of hematopoietic progenitors (CD45 + Sca1 + c-Kit + cells) and HSC (SLAM; LSK CD150 + CD48 − cells) were determined by flow cytometry. Data are shown as means ± SD; n = 4 mice. E Sca1 + cells (10 5 cells) isolated from mice were analyzed on semi-solid methylcellulose media for growth of murine hematopoietic CFU. Data show the percentage of total CFU and CFU-GM per Sca1 + cells, as well as the distribution among colonies. Data are shown as means ± SD; n = 4 mice. F Sca1 + cells (3 × 10 5 cells) were injected in C57BL/6.SJL (Ly.1) mice and the hematopoietic reconstitution was examined by flow cytometry, 4 weeks after the transplantation. Absolute number of CD45.2 total and Lin − BM cells. Data are shown as means ± SD; n = 3 transplanted mice. G Hematopoietic reconstitution for progenitors (LSK cells) and HSC (SLAM cells). Absolute number of CD45.2 cells in BM. Data are shown as means ± SD; n = 3 transplanted mice. On this figure, P value is measured by one-way Anova with Tukey’s multiple comparison test; ** P < 0.01; *** P < 0.001; ns, non-significant.

Article Snippet: We used the following antibodies; Sca1-APC-Cy7 (1:100, 108126, Biolegend, Paris, France), Sca1-VB-FITC (1:100, 130-116-490, Miltenyi Biotec), CD48-PE-Cy7 (1:100, 560731, BD Biosciences, Le Pont de Claix, France), CD48-FITC (1:100, 103404, Biolegend), CD48-APC (1:100, 130-124-727, Miltenyi Biotec), c-Kit-BV650 (1:100, 135125, Biolegend), c-Kit-PE-Cy7 (1:100, 558163, BD Biosciences), CD150-PerCP-Cy5.5 (1:100, 115921, Biolegend), murine CD45.2-Vioblue (1:100, 130-102-980, Miltenyi Biotec).

Techniques: Injection, Flow Cytometry, Control, Isolation, Transplantation Assay, Comparison

Mice were injected with 5 × 10 5 cells (T-ALL) or 10 5 cells (B-ALL) and murine Sca1 + cells were recovered when mice were developing ALL disease (day 35). A The number of Sca1 + cells recovered from the BM of control NSG mice and PDX mice developing T-ALL or B-ALL. Data are shown as means ± SD; n = 5 mice. B Analysis of Sca1 + cells by flow cytometry showing loss of hematopoietic progenitors (CD45 + c-Kit + ) and HSC (SLAM; CD150 + CD48 − ) in T-ALL and B-ALL PDX mice. Data are shown as means ± SD; n = 5 mice. C 25% of the Sca1 + cells were cultured in methylcellulose media and hematopoietic CFU were observed at day 7; scale bar represents 5 mm. Data are shown as means ± SD; n = 3 mice. D 75% of the Sca1 + cells were cultured in media for growth of mesenchymal CFU for 10 days, scale bar represents 1 cm. Data are shown as means ± SD; n = 3 mice. On this figure, P value is measured by one-way Anova with Tukey’s multiple comparison test; *** P < 0.001; **** P < 0.0001; ns non-significant.

Journal: Cell Death & Disease

Article Title: Acute lymphoblastic leukemia-derived extracellular vesicles affect quiescence of hematopoietic stem and progenitor cells

doi: 10.1038/s41419-022-04761-5

Figure Lengend Snippet: Mice were injected with 5 × 10 5 cells (T-ALL) or 10 5 cells (B-ALL) and murine Sca1 + cells were recovered when mice were developing ALL disease (day 35). A The number of Sca1 + cells recovered from the BM of control NSG mice and PDX mice developing T-ALL or B-ALL. Data are shown as means ± SD; n = 5 mice. B Analysis of Sca1 + cells by flow cytometry showing loss of hematopoietic progenitors (CD45 + c-Kit + ) and HSC (SLAM; CD150 + CD48 − ) in T-ALL and B-ALL PDX mice. Data are shown as means ± SD; n = 5 mice. C 25% of the Sca1 + cells were cultured in methylcellulose media and hematopoietic CFU were observed at day 7; scale bar represents 5 mm. Data are shown as means ± SD; n = 3 mice. D 75% of the Sca1 + cells were cultured in media for growth of mesenchymal CFU for 10 days, scale bar represents 1 cm. Data are shown as means ± SD; n = 3 mice. On this figure, P value is measured by one-way Anova with Tukey’s multiple comparison test; *** P < 0.001; **** P < 0.0001; ns non-significant.

Article Snippet: We used the following antibodies; Sca1-APC-Cy7 (1:100, 108126, Biolegend, Paris, France), Sca1-VB-FITC (1:100, 130-116-490, Miltenyi Biotec), CD48-PE-Cy7 (1:100, 560731, BD Biosciences, Le Pont de Claix, France), CD48-FITC (1:100, 103404, Biolegend), CD48-APC (1:100, 130-124-727, Miltenyi Biotec), c-Kit-BV650 (1:100, 135125, Biolegend), c-Kit-PE-Cy7 (1:100, 558163, BD Biosciences), CD150-PerCP-Cy5.5 (1:100, 115921, Biolegend), murine CD45.2-Vioblue (1:100, 130-102-980, Miltenyi Biotec).

Techniques: Injection, Control, Flow Cytometry, Cell Culture, Comparison